POLD1 and endometrial cancer: On balance, overexpression of POLD1 p.D402N directly increased mutation counts, SNP, INDEL, and imparted a POLD1 exonuclease deficiency specific mutational signature on the cancer genome in our engineered endometrial cancer cell line model.